- Home
- TEVA vs MKL Comparison
TEVA vs MKL Comparison
Compare TEVA & MKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- MKL
- Stock Information
- Founded
- TEVA 1901
- MKL 1930
- Country
- TEVA Israel
- MKL United States
- Employees
- TEVA N/A
- MKL N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- MKL Property-Casualty Insurers
- Sector
- TEVA Health Care
- MKL Finance
- Exchange
- TEVA Nasdaq
- MKL Nasdaq
- Market Cap
- TEVA 21.2B
- MKL 24.4B
- IPO Year
- TEVA N/A
- MKL 1986
- Fundamental
- Price
- TEVA $18.95
- MKL $1,912.83
- Analyst Decision
- TEVA Strong Buy
- MKL Hold
- Analyst Count
- TEVA 7
- MKL 3
- Target Price
- TEVA $24.71
- MKL $1,820.33
- AVG Volume (30 Days)
- TEVA 10.1M
- MKL 39.4K
- Earning Date
- TEVA 11-05-2025
- MKL 10-29-2025
- Dividend Yield
- TEVA N/A
- MKL N/A
- EPS Growth
- TEVA N/A
- MKL 8.84
- EPS
- TEVA N/A
- MKL 167.05
- Revenue
- TEVA $16,628,000,000.00
- MKL $16,454,135,999.00
- Revenue This Year
- TEVA $4.07
- MKL N/A
- Revenue Next Year
- TEVA $0.81
- MKL $1.39
- P/E Ratio
- TEVA N/A
- MKL $11.45
- Revenue Growth
- TEVA 2.08
- MKL 1.66
- 52 Week Low
- TEVA $12.47
- MKL $1,494.00
- 52 Week High
- TEVA $22.80
- MKL $2,075.92
- Technical
- Relative Strength Index (RSI)
- TEVA 66.51
- MKL 40.54
- Support Level
- TEVA $17.89
- MKL $1,925.00
- Resistance Level
- TEVA $18.96
- MKL $1,967.06
- Average True Range (ATR)
- TEVA 0.52
- MKL 27.94
- MACD
- TEVA 0.06
- MKL -1.79
- Stochastic Oscillator
- TEVA 91.24
- MKL 6.33
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About MKL Markel Group Inc.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.